Prevenar 13 Vaccine 0.5ml
Netmeds First Membership
Quick Links
Introduction About PREVENAR 13 VACCINE
PREVENAR 13 VACCINE contains Pneumococcal Polysaccharide Serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) conjugated with non-toxic diphtheria CRM197 protein. It is used in infants and toddlers (from 6 weeks to 5 years) to manage invasive diseases and otitis media caused by specific streptococcus pneumoniae serotypes. It is used in children and adolescents (from 6 years to 17 years) to manage invasive diseases caused by specific streptococcus pneumoniae serotypes. It is used in adults (above 18 years) to manage pneumonia and invasive diseases caused by specific streptococcus pneumoniae serotypes.
Streptococcus pneumoniae, or pneumococcus, is a bacteria that may cause certain invasive diseases such as sepsis, meningitis, pleural empyema, and bacteremia. Sepsis is a life-threatening condition developed due to the extreme response of the body to the infection, which is characterised by symptoms such as confusion, dizziness, and diarrhoea.
Meningitis is the infection of the membranes covering the brain, which is characterised by symptoms such as fever, headache, and stiff neck. Pleural empyema is a lung infection that causes pus formation in the membrane covering the lungs and is characterised by symptoms such as chest pain, dry cough, and fever. Bacteraemia is an infection of the blood that is characterised by symptoms such as fever, chills, and low blood pressure.
Otitis media is an infection occurring in the middle ear, which is characterised by symptoms such as pain in the ears, headaches, and fever. Pneumonia is an infection occurring in the air sacs of one or both lungs that is characterised by symptoms such as fever, chills, and shortness of breath.
PREVENAR 13 VACCINE is not recommended for use if you are allergic to pneumococcal polysaccharide serotypes or diphtheria toxoids. It should be used with caution in patients with chronic liver disease, chronic kidney disease, and nephrotic disease.
PREVENAR 13 VACCINE should be used with caution in pregnant and breastfeeding women. It is not recommended for use in children (below 6 weeks). PREVENAR 13 VACCINE should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before receiving it.
The common side effects associated with the use of PREVENAR 13 VACCINE are reactions at the site of injection (such as redness, swelling, and tenderness), limitations in the injected limb, mild to moderate fever, irritability, decreased appetite, increased sleep, or decreased sleep. Contact your doctor or a nearby hospital if any of the conditions worsens or persists.
Uses Of PREVENAR 13 VACCINE
- Prevent invasive diseases and otitis media caused by specific streptococcus pneumoniae serotypes in infants and toddlers
- Prevent the invasive diseases caused by specific streptococcus pneumoniae serotypes in children and adolescents
- Prevent pneumonia and invasive diseases caused by specific streptococcus pneumoniae serotypes in adults
How PREVENAR 13 VACCINE Works
PREVENAR 13 VACCINE helps to manage diseases caused by specific streptococcus pneumonia serotypes where the Pneumococcal Polysaccharide Vaccine stimulates the production of certain neutralizing antibodies that bind to the virus and manage it from infecting cells thus providing protection from the infection to be caused by specific streptococcus pneumoniae serotypes in future.
How to use PREVENAR 13 VACCINE
PREVENAR 13 VACCINE will be given to you only by a doctor or a nurse into a muscle as an intramuscular injection in the anterolateral aspect of the thigh in infants or the deltoid muscle (a muscle in the upper arm) in children and adults. Avoid injecting the vaccine in the gluteal area or areas where major nerve trunks and/or blood vessels can be located. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Side Effects Of PREVENAR 13 VACCINE
Common
- reactions at the site of injection such as redness, swelling, and tenderness
- limitation of the injected limb
- mild to moderate fever
- irritability
- decreased appetite
- increased sleep
- decreased sleep
- weakness
- headache
- chills
- rash
- muscle pain
- joint pain
- vomiting
Uncommon
- bronchiolitis (inflammation and congestion in small airways of the lungs)
- gastroenteritis (inflammation in stomach and intestines)
- pneumonia (inflammation in lungs particularly air sacs)
Stop receiving PREVENAR 13 VACCINE and contact your doctor if you experience any of the following side effects:
- signs of anaphylactic reactions such as severe rashes, shortness of breath, and noisy breathing
- bronchiolitis (inflammation and congestion in small airways of the lungs)
- gastroenteritis (inflammation in stomach and intestines)
- pneumonia (inflammation in lungs particularly air sacs)
How To Manage Side Effects
Headache
Take rest and drink plenty of water. Avoid drinking alcohol and skipping meals. Do not strain your eyes by watching the screen for a long time. Consult your doctor if the condition persists for a long time or gets worse.
Muscle Cramps
Stay active and try to do your daily activities. Use ice or heat packs on the affected area to reduce pain and swelling. Try doing specific exercises and stretches for the painful region of the body.
Nausea And Vomiting
Stick to simple meals. Avoid eating rich or spicy food. Get a lot of rest. Avoid drinking coffee, alcohol, or smoking. Consult your doctor if the symptom gets worse.
Warning & Precautions
Pregnancy
Use with CautionPREVENAR 13 VACCINE should be used with caution in pregnant women. Consult your doctor before receiving the medicine.
Breastfeeding
Use with CautionPREVENAR 13 VACCINE should be used with caution in breastfeeding women. Consult your doctor before receiving the medicine.
Kidney
Use with CautionPREVENAR 13 VACCINE should be used with caution in patients with chronic kidney disease and nephrotic syndrome. Consult your doctor before receiving it.
Liver
Use with CautionPREVENAR 13 VACCINE should be used with caution in patients with chronic liver disease. Consult your doctor before receiving it.
Allergy
ContraindicatedPREVENAR 13 VACCINE is not recommended for use if you are allergic to pneumococcal polysaccharide serotypes, diphtheria toxoids, or any other ingredients of this medicine. Consult your doctor before receiving it.
Use In Pediatrics
Consult your doctorPREVENAR 13 VACCINE is not recommended for use in infants (below 6 weeks). It should be used with caution in children and adolescents (below 18 years). Consult your doctor before receiving it.
Use In Geriatrics
Use with CautionIt should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before receiving it.
Others
Before receiving PREVENAR 13 VACCINE, inform your doctor if you:
- have congenital or acquired splenic dysfunction
- have HIV infection
- have any malignancy (cancer)
- have undergone hematopoietic stem cell transplant (infusion of stem cells in the body)
- were born prematurely
Interactions
A. Drug-Drug interactions:
Inform your doctor if you are taking or have recently taken any other medicines while taking PREVENAR 13 VACCINE as a precaution.
Overdosage:
PREVENAR 13 VACCINE will be given to you only by a doctor or nurse in a hospital, so it is unlikely to receive an overdose. However, most individuals remain asymptomatic but if you experience any unusual symptoms, consult your doctor immediately or visit the nearby hospital.
Synopsis
| Drug | : | Pneumococcal Polysaccharide Vaccine (PPV): 13 Valet |
| Pharmacological Category | : | Vaccine |
| Therapeutic Indication | : | Prevent the invasive diseases, pneumonia and otitis media caused by specific Streptococcus Pneumoniae Serotypes |
| Dosage Forms | : | Injection |
More Information
- Keep the medicine out of reach of children
- Do not freeze PREVENAR 13 VACCINE
FAQs About PREVENAR 13 VACCINE
Q: What is PREVENAR 13 VACCINE used for?
A: PREVENAR 13 VACCINE is used in infants and toddlers (from 6 weeks to 5 years) to manage invasive diseases and otitis media caused by specific Streptococcus pneumoniae serotypes. It is used in children and adolescents (from 6 years to 17 years) to manage invasive diseases caused by specific Streptococcus pneumoniae serotypes. PREVENAR 13 VACCINE is used in adults (over 18 years old) to manage pneumonia and invasive diseases caused by specific streptococcus pneumoniae serotypes.
Q: What side effects are seen with PREVENAR 13 VACCINE?
A: The common side effects associated with the use of PREVENAR 13 VACCINE are reactions at the site of injection (such as redness, swelling, and tenderness), limitations in the injected limb, mild to moderate fever, irritability, decreased appetite, increased sleep, or decreased sleep. Contact your doctor or a nearby hospital if any of the conditions worsens or persists.
Q: Who should avoid receiving PREVENAR 13 VACCINE?
A: PREVENAR 13 VACCINE is not recommended for use if you are allergic to pneumococcal polysaccharide serotypes or diphtheria toxoids. It is not recommended for use in infants (below 6 weeks). Consult your doctor before receiving PREVENAR 13 VACCINE.
Q: What is the method of receiving PREVENAR 13 VACCINE?
A: PREVENAR 13 VACCINE will be given to you only by a doctor or a nurse and will be injected into a muscle as an intramuscular injection in the anterolateral aspect of the thigh in infants or the deltoid muscle (a muscle in the upper arm) in children and adults.
Avoid injecting the vaccine in the gluteal area or areas where a major nerve trunk and/or blood vessel can be located. Your doctor will determine the correct dose and duration for you depending upon your age, body weight, and disease condition.
Q: Is PREVENAR 13 VACCINE safe to use in liver patients?
A: PREVENAR 13 VACCINE should be used with caution in patients with chronic liver disease (liver diseases that have been prevailing in the body for a long time and are worsening with time). Consult your doctor before receiving PREVENAR 13 VACCINE.
Q: Is PREVENAR 13 VACCINE safe to use in kidney patients?
A: PREVENAR 13 VACCINE should be used with caution in patients with chronic kidney disease or nephrotic syndrome (a disorder causing excessive protein loss in the urine). Consult your doctor before receiving PREVENAR 13 VACCINE.
Q: How to store PREVENAR 13 VACCINE?
A: Keep PREVENAR 13 VACCINE out of reach of children. Do not freeze this product. Store it at 2°C to 8°C (36°F to 46°F). Use only refrigerated products and keep them away from freezer compartments.
Q: Who should be vaccinated with PREVENAR 13 VACCINE?
A: PREVENAR 13 VACCINE is used in infants and toddlers (from 6 weeks to 5 years) to manage invasive diseases and otitis media caused by specific Streptococcus pneumoniae serotypes. PREVENAR 13 VACCINE is used in children and adolescents (from 6 years to 17 years) to manage invasive diseases caused by specific Streptococcus pneumoniae serotypes. PREVENAR 13 VACCINE is used in adults (over 18 years old) to manage pneumonia and invasive diseases caused by specific streptococcus pneumoniae serotypes.
References
1. J. Larry Jameson, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, J. Loscalzo. Pneumonia. Harrison’s Principles of Internal Medicine. Twentieth Edition. 2018. Page – 914.
2. Stefaan J. Vandecasteele, Sara Ombelet, Sophie Blumental, Willy E. Peetermans. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. NIH National Library of Medicine. National Centre for Biotechnology Information. PMC PubMed Central. May 2015. [Assessed 20th August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440476/
3. Suvi Harmala, Constantinos Parisinos, Laura Shallcross, Alastair O’Brien, Andrew Hayward. Effectiveness of pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver disease: a protocol for a systematic review. NIH National Library of Medicine. National Centre for Biotechnology Information. PMC PubMed Central. March 2018. [Assessed 20th August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857657/
4. Wyeth Pharmaceuticals Inc. PREVNAR 13. [Revised in August 2017] [Assessed 20th August 2022] https://www.fda.gov/media/107657/download
Useful Diagnostic Tests
- Blood Test
- Urine Test
Author Details
